AUTHORAnaïs Gautron
CATEGORYnews
PUBLISHED ATMarch 4, 2026

In this article

Medical guidance at the key moment of results: clarity, trust, and supportA fully digital pathwayAbout LucisAbout Livi
Lucis and Livi launch a new digital preventive health pathway in France
news

Lucis and Livi launch a new digital preventive health pathway in France

Analysis of 110 biomarkers and preventive teleconsultationMarch 4, 2026

With this collaboration, Lucis strengthens its leadership position by offering a comprehensive preventive care pathway: analysis of 110 biomarkers, a personalized assessment (AI-generated and medically validated), and a preventive teleconsultation provided when results are delivered.

Lucis, a preventive health platform, and Livi, a leading teleconsultation provider, announce a collaboration to build a new digital preventive health pathway in France. The offering includes an advanced analysis of 110 biomarkers, a personalized assessment generated by AI and validated by physicians, as well as a preventive medicine teleconsultation with practitioners trained in this field. The objective is to transform medical information into concrete action.

Medical guidance at the key moment of results: clarity, trust, and support

Biological test results can be difficult to interpret and sometimes anxiety-inducing, especially when they are not accompanied by clear explanations. With the Lucis × Livi pathway, teleconsultation becomes the most reliable way to understand your results. The dedicated exchange between patient and physician helps put results into perspective, address any questions, and prioritize the next steps outlined in the personalized action plan available on the Lucis platform.

“Lucis was designed to make preventive health clearer and more actionable.
However, we observed that one key moment can still raise doubts: receiving test results. With Livi, we are adding a medical consultation at the moment it is most useful, to help each individual understand their results and prioritize their next steps. Our ambition is to offer a comprehensive pathway, without replacing the traditional care pathway.” Maxime Berthelot
CEO and Co-founder • Lucis

A fully digital pathway

Lucis operates on a preventive health subscription model that includes the analysis of 110 biomarkers in blood, urine, and saliva, along with a health questionnaire. The results are then integrated into the Lucis platform, accompanied by a personalized action plan. At this stage, users can book a follow-up teleconsultation on Livi with practitioners trained in preventive medicine to review and contextualize their results, ask questions, and discuss their action plan. This consultation is part of a preventive care pathway and does not constitute a diagnostic promise. However, when medically justified, the physician may prescribe additional tests or treatments, or refer the patient to their primary care physician and/or a specialist.

“We are delighted to partner with Lucis to make prevention more tangible and accessible. This collaboration enables users to better understand their results, ask their questions to a physician, and receive guidance to turn medical information into simple decisions tailored to their situation. This is precisely the role teleconsultation can play: providing a clear medical framework at the right moment, in line with best practices.” Fredrik Edström
Managing Director, Livi France

About Lucis

Lucis is a start-up founded in 2025 in Paris by Maxime Berthelot and Baptiste Debever. It develops a preventive health platform supported by certified laboratories across Europe, a multidisciplinary medical team, and the analysis of more than 180 biomarkers to help individuals better understand and monitor their health over time. Lucis currently operates in France, the United Kingdom, Ireland, and Portugal, and is backed by General Catalyst, Y Combinator, Kima Ventures, Motier Ventures, North South Ventures, and several business angels.

About Livi

Established in France in 2018, Livi is a healthcare provider and a pioneer in teleconsultation. Approved by the French Ministry of Health, Livi delivers an innovative and rigorous healthcare offering based on respect for the care pathway and a digi-physical approach, with two centers located in the Île-de-France region. Its parent company, Kry, is the Swedish teleconsultation leader playing a major role in the digitalization of healthcare across Europe, with operations in four countries (Sweden, Norway, the UK, and France). Livi employs more than 800 general practitioners and specialists registered with the French Medical Council, as well as psychologists.

Teleconsultation is available 7 days a week, 24 hours a day* via the Livi website or the mobile application available on smartphone or tablet.
Livi is not an emergency service.

This article has been translated from French using AI.

Request an AI summary of Lucis

ChatGPTClaudeGeminiGrokPerplexity
© Lucis 2026. All rights reserved.